Europe PMC requires Javascript to function effectively.

Either your web browser doesn't support Javascript or it is currently turned off. In the latter case, please turn on Javascript support in your web browser and reload this page.

Search life-sciences literature (45,100,050 articles, preprints and more)

Search results

1-25 of 147 results

Sort by:

Relevance ^{Relevance: This is determined based on a ranking of criteria including term frequency, rarity of term, recency of article, whether there is a Title or Author field match, etc.}

Times cited

Date

1 2 3 Next ...

Reirradiation of squamous cell carcinoma of the head and neck with external photons: A practical review of the literature.
Queyrel É, Lapierre A, Pointreau Y, Lapeyre M, Biau J, Ruffier A
Cancer Radiother, 28(6-7):580-585, 10 Oct 2024
Cited by: 0 articles | PMID: 39389843
Add to export list Review
[Update of guidelines of the AFSOS, SFRO, SFH, SFNCM, SFCE, GFRP for the management of radio-induced nausea and vomiting].
Faivre JC, Demoor-Goldschmitt C, Beddok A, Schmitt A, Malgras A, Quilliot D, Fabre J, Perrot A, Jovenin N, Dupin C, Pointreau Y, Scotté F, Bensadoun RJ, Charzat V, Thariat J
Bull Cancer, 111(11):1065-1076, 09 Oct 2024
Cited by: 0 articles | PMID: 39384523
Add to export list
Adapted EXTREME regimen in the first-line treatment of fit, older patients with recurrent or metastatic head and neck squamous cell carcinoma (ELAN-FIT): a multicentre, single-arm, phase 2 trial.
Guigay J, Le Caer H, Ferrand FR, Geoffrois L, Saada-Bouzid E, Fayette J, Sire C, Cupissol D, Blot E, Guillet P, Pavillet J, Bozec L, Capitain O, Rolland F, Debourdeau P, Pointreau Y, Falandry C, Lopez S, Coutte A, [...] and GORTEC
Lancet Healthy Longev, 5(6):e392-e405, 14 May 2024
Cited by: 0 articles | PMID: 38759667
Add to export list
[Proposal for the delineation of postoperative primary clinical target volumes in maxillary sinus and nasal cavity cancers].
Guillemin F, Blanchard P, Boisselier P, Brahimi Y, Calugaru V, Coutte A, Gillon P, Graff P, Liem X, Modesto A, Pointreau Y, Racadot S, Sun XS, Bellini R, Pham Dang N, Saroul N, Bourhis J, Thariat J, Biau J, Lapeyre M
Cancer Radiother, 28(2):218-227, 09 Apr 2024
Cited by: 0 articles | PMID: 38599940
Add to export list
Pembrolizumab plus concurrent chemoradiotherapy versus placebo plus concurrent chemoradiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (KEYNOTE-412): a randomised, double-blind, phase 3 trial.
Machiels JP, Tao Y, Licitra L, Burtness B, Tahara M, Rischin D, Alves G, Lima IPF, Hughes BGM, Pointreau Y, Aksoy S, Laban S, Greil R, Burian M, Hetnał M, Delord JP, Mesía R, Taberna M, Waldron JN, [...] KEYNOTE-412 Investigators
Lancet Oncol, 25(5):572-587, 29 Mar 2024
Cited by: 8 articles | PMID: 38561010
Add to export list
Metastases-directed radiotherapy in castration resistant oligo metastatic prostate cancer: A multicentric retrospective study from the French group COLib.
Chamois J, Septans AL, Schipman B, Gross E, Blanchard N, Passerat V, Debelleix C, Hemery CG, Latorzeff I, Pointreau Y
Clin Transl Radiat Oncol, 46:100762, 17 Mar 2024
Cited by: 1 article | PMID: 38572302 | PMCID: PMC10987832
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Cetuximab versus methotrexate in first-line treatment of older, frail patients with inoperable recurrent or metastatic head and neck cancer (ELAN UNFIT): a randomised, open-label, phase 3 trial.
Guigay J, Ortholan C, Vansteene D, Cupissol D, Even C, Kaminsky MC, Sire C, Blot E, Debourdeau P, Bozec L, Saada-Bouzid E, Fayette J, Dalloz P, Pointreau Y, Caer HL, Falandry C, Digue L, Braccini A, Lopez S, [...] Unicancer GERICO and H&N groups and the GORTEC
Lancet Healthy Longev, 5(3):e182-e193, 01 Mar 2024
Cited by: 0 articles | PMID: 38432247
Add to export list
Stereotactic body radiation therapy for adrenal gland metastases: A multi-institutional outcome analysis.
Yuste C, Passerat V, Calais G, Schipman B, Vaugier L, Paumier A, Huertas A, Hemery CG, Debelleix C, Chamois J, Blanchard N, Septans AL, Pointreau Y
Clin Transl Radiat Oncol, 45:100708, 07 Dec 2023
Cited by: 1 article | PMID: 38162282 | PMCID: PMC10757246
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
[Clinical research in private sector: Which strategic analysis?]
Ruffier A, Pointreau Y, Sacier V, Balavoine M, Lamrani-Ghaouti A, Guihard S, Rivera S
Cancer Radiother, 27(6-7):469-473, 16 Aug 2023
Cited by: 0 articles | PMID: 37596122
Add to export list
Management of head and neck carcinomas with synchronous or metachronous oligometastatic disease: Role of locoregional radiotherapy and metastasis-directed radiotherapy.
Tonneau M, Nebbache R, Larnaudie A, Thureau S, Pointreau Y, Blanchard P, Thariat J
Cancer Radiother, 28(1):83-92, 22 Aug 2023
Cited by: 1 article | PMID: 37620212
Add to export list
[Clinical research in general hospital centres in France, strengths and weaknesses].
Argo-Leignel D, Bouju P, Le Saux M, Leissen N, Guégan R, Pointreau Y, Alexandre Y, Bera G
Cancer Radiother, 27(6-7):460-463, 10 Aug 2023
Cited by: 0 articles | PMID: 37573194
Add to export list
Long-term results from a clinical study of xevinapant plus chemoradiotherapy in people with high-risk locally advanced squamous cell carcinoma of the head and neck: a plain language summary.
Tao Y, Sun XS, Pointreau Y, Tourneau CL, Sire C, Gollmer K, Crompton P, Bourhis J
Future Oncol, 19(26):1769-1776, 13 Jul 2023
Cited by: 1 article | PMID: 37439181
Add to export list
Brain radiotherapy in patients treated for a newly diagnosed primary central nervous system lymphoma: professional practice evaluation in 19 French centers.
Thomas-Joulié A, Houillier C, Antoni D, Créhange G, Jouglar E, Colin P, Benchalal M, Lang P, Alfonsi M, Hamidou H, Coutte A, Ahrweiller F, Dadoun N, Pointreau Y, Ammarguellat H, Bernier-Chastagner V, Belkacemi Y, Vieillot S, Hoang-Xuan K, [...] Feuvret L
Acta Oncol, 62(6):648-656, 20 Jun 2023
Cited by: 1 article | PMID: 37338525
Add to export list
Stereotactic body radiotherapy for mediastinal lymph node with CyberKnife®: Efficacy and toxicity.
Camps-Malea A, Pointreau Y, Chapet S, Calais G, Barillot I
Cancer Radiother, 27(3):225-232, 19 Apr 2023
Cited by: 0 articles | PMID: 37080855
Add to export list
Practical and technical key challenges in head and neck adaptive radiotherapy: The GORTEC point of view.
Delaby N, Barateau A, Chiavassa S, Biston MC, Chartier P, Graulières E, Guinement L, Huger S, Lacornerie T, Millardet-Martin C, Sottiaux A, Caron J, Gensanne D, Pointreau Y, Coutte A, Biau J, Serre AA, Castelli J, Tomsej M, [...] Badey A
Phys Med, 109:102568, 02 Apr 2023
Cited by: 2 articles | PMID: 37015168
Add to export list Review
Randomized phase II trial in prostate cancer with hormone-sensitive OligometaSTatic relapse: Combining stereotactic ablative radiotherapy and durvalumab (POSTCARD GETUG P13): Study protocol.
Rogé M, Pointreau Y, Sargos P, Meyer E, Schick U, Hasbini A, Rio E, Bera G, Ruffier A, Quivrin M, Chasseray M, Latorzeff I, Martin E, Guimas V, Pommier P, Leroy T, Ronchin P, Lepinoy A, Grand A, [...] Supiot S
Clin Transl Radiat Oncol, 40:100613, 08 Mar 2023
Cited by: 5 articles | PMID: 36968576 | PMCID: PMC10034400
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Extended follow-up of a phase 2 trial of xevinapant plus chemoradiotherapy in high-risk locally advanced squamous cell carcinoma of the head and neck: a randomised clinical trial.
Tao Y, Sun XS, Pointreau Y, Le Tourneau C, Sire C, Kaminsky MC, Coutte A, Alfonsi M, Calderon B, Boisselier P, Martin L, Miroir J, Ramee JF, Delord JP, Clatot F, Rolland F, Villa J, Magne N, Elicin O, [...] Bourhis J
Eur J Cancer, 183:24-37, 09 Jan 2023
Cited by: 10 articles | PMID: 36796234
Add to export list
Physical Activity Program for the Survival of Elderly Patients With Lymphoma: Study Protocol for Randomized Phase 3 Trial.
Dubu J, Boyas S, Roland V, Landry S, Septans AL, Balavoine M, Bourgeois H, Pointreau Y, Denis F, Letellier C, Le Dû K
JMIR Res Protoc, 11(11):e40969, 25 Nov 2022
Cited by: 0 articles | PMID: 36427234 | PMCID: PMC9736768
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
AIRO GORTEC consensus on postoperative radiotherapy (PORT) in low-intermediate risk early stages oral squamous cell cancers (OSCC).
Merlotti A, Alterio D, Orlandi E, Racadot S, Bonomo P, Franco P, D'Angelo E, Ursino S, Pointreau Y, Lapeyre M, Graff P, Di Rito A, Argenone A, Musio D, De Felice F, Dionisi F, Fanetti G, D'Onofrio I, Belgioia L, [...] Thariat J
Radiother Oncol, 177:95-104, 03 Nov 2022
Cited by: 3 articles | PMID: 36336113
Add to export list Review
AFSOS-SFRO-SFH-SFNEP-SFCE-GFRP guidelines on radio-induced nausea and vomiting.
Faivre JC, Tomaszewski F, Demoor-Goldschmitt C, Beddok A, Malgras A, Schmitt A, Fabre J, Perrot A, Jovenin N, Salleron J, Clavère P, Pointreau Y, Scotté F, Bensadoun RJ, Block V, Thariat J
Crit Rev Oncol Hematol, 180:103825, 09 Oct 2022
Cited by: 0 articles | PMID: 36223807
Add to export list Review
Head and neck cancers volume reduction: should we reduce our prophylactic node radiation to spare the antitumor immune response?
El Houat Y, Bouvier L, Baty M, Palard-Novello X, Pointreau Y, de Crevoisier R, Castelli J
Cancer Radiother, 26(6-7):916-920, 06 Sep 2022
Cited by: 0 articles | PMID: 36075834
Add to export list Review
[Impact of IMRT for neoadjuvant rectal cancer?]
Pointreau Y, Moreau J, Vendrely V, Schipman B
Cancer Radiother, 26(6-7):865-870, 05 Sep 2022
Cited by: 1 article | PMID: 36064531
Add to export list Review
[Hematological pathologies: the most successful model of de-escalation in radiotherapy].
Coutte A, Pointreau Y
Cancer Radiother, 26(6-7):925-930, 11 Aug 2022
Cited by: 0 articles | PMID: 35965244
Add to export list Review
[French careers in oncology radiotherapy: Crossing views].
Legouté F, Lesueur P, El Kabbaj O, Ghannam Y, Michalet M, Monpetit E, Azria D, Giraud P, Calais G, Pointreau Y, Ollivier L
Cancer Radiother, 27(1):75-79, 23 Aug 2022
Cited by: 0 articles | PMID: 36008260
Add to export list
[Erratum to "Radiotherapy for laryngeal cancers" [Cancer Radiother. 26 (2022) 206-12]].
Biau J, Pointreau Y, Blanchard P, Khamphan C, Giraud P, Lapeyre M, Maingon P
Cancer Radiother, 26(5):754, 05 Aug 2022
Cited by: 0 articles | PMID: 35934620
Add to export list

1-25 of 147 results

1 2 3 Next ...

Search life-sciences literature (45,100,050 articles, preprints and more)

Search results

Partnerships & funding